Go back to the Europarl portal

Choisissez la langue de votre document :

  • bg - български
  • es - español
  • cs - čeština
  • da - dansk
  • de - Deutsch
  • et - eesti keel
  • el - ελληνικά
  • en - English (Selected)
  • fr - français
  • ga - Gaeilge
  • hr - hrvatski
  • it - italiano
  • lv - latviešu valoda
  • lt - lietuvių kalba
  • hu - magyar
  • mt - Malti
  • nl - Nederlands
  • pl - polski
  • pt - português
  • ro - română
  • sk - slovenčina
  • sl - slovenščina
  • fi - suomi
  • sv - svenska
Parliamentary questions
PDF 42kWORD 10k
31 August 2021
P-004007/2021
Priority question for written answer  P-004007/2021
to the Commission
Rule 138
Ivan Vilibor Sinčić (NI)
 Answer in writing 
 Subject: Liability for vaccine side effects – citizens' rights under the Product Liability Directive and the precedent set by the no-fault compensation programme

In response to my earlier parliamentary question E-000344/2021(1) to the Commission, I was informed that manufacturers or pharmaceutical companies would be held liable for the side effects of the COVID-19 vaccines in accordance with the Product Liability Directive.

1. Have the Member States or the Commission concluded additional legal provisions regarding liability for side effects – safeguards that favour manufacturers?

2. Have the Member States or the Commission entered into any guarantees or agreements with pharmaceutical companies concerning compensation for damages paid out by pharmaceutical companies following any successful lawsuits brought by citizens in respect of side effects from their products(2)?

3. Was the incorporation of safeguards concerning compensation for damages paid out by producers a condition for concluding the vaccine supply contracts with these producers?

(1)https://www.europarl.europa.eu/doceo/document/E-9-2021-000344_EN.html
(2)https://www.gavi.org/vaccineswork/covax-no-fault-compensation-programme-explained
Original language of question: HR
Last updated: 1 September 2021Legal notice - Privacy policy